A hydrochloride salt of Selegiline, which is a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. It is a selective, irreversible inhibitor of Type B monoamine oxidase. Selegiline has no anti-Parkinson effects of its own and must always be given in combination with levodopa/carbidopa. Reference standards of Selegiline Hydrochloride API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Selegiline Hydrochloride
Catalogue No.:PA 19 04000
CAS :
Molecular Formula : C13H18ClN
Molecular Weight : 223.74
(2EZ)-3-Chloro-N-methyl-N-[(1RS)-1-methyl-2-phenylethyl]prop-2-en-1-amine
Catalogue No.:PA 19 0040070
N-[(1RS)-1-Methyl-2-phenylethyl]prop-2-yn-1-amine Hydrochloride (rac-Demethylselegiline Hydrochloride)
Catalogue No.:PA 19 0040040
Molecular Formula : C12H16ClN
Molecular Weight : 209.72
(S)-Selegiline
Catalogue No.:PA 19 0040050
Molecular Formula : C13H17N
Molecular Weight : 187.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
